The results come after Aphria ( APHA) became the rare pot stock to break out of a base, after weak sales growth, financing concerns and the coronavirus pandemic pulled the industry lower through last year. Aphria reported a net loss of 39 Canadian cents a share, or 29 cents.
Why is Aphria stock falling hard today?
Apr 12, 2021 · Shares of Aphria ( APHA ) were tanking by 13.2% as of 10:16 a.m. EDT on Monday while shares of Tilray ( TLRY ) were falling by 11.9%. The declines for both stocks came after Aphria reported ...
Should investors look to the future for APHA stock?
Apr 12, 2021 · Cannabis darling Aphria (NASDAQ: APHA) is stumbling Monday morning. A combination of factors, including a wider-than-expected loss in …
How much should Aphria stock have traded at before the merger?
Dec 21, 2020 · What happened. Marijuana stock Aphria ( APHA ) declined notably on Monday, shedding almost 5.8% of its value. While investors have already digested last week's news of the company's merger with ...
Is Aphria’s strategy working?
Jun 03, 2021 · While Tilray investors have kept their shares after the merger, Aphria stockholders received 0.8381 Tilray shares for each Aphria share that …
What happens to APHA shares after merger?
After Aphria and Tilray merge, the combined entity will be called Tilray and the shares will continue to trade on Nasdaq under the ticker TLRY. Yet the terms of the deal look more advantageous to Aphria. First of all, the company's CEO and chairman, Irwin Simon, will remain at the helm.Mar 22, 2021
Is Aphria a good stock to buy now?
Currently, Aphria is trading at close to 0.73 times Tilray's share price. The single most compelling reason to buy Aphria stock right now is that this ratio absolutely must increase to the 0.8381 ratio included in the merger agreement.Mar 11, 2021
Will APHA stock turn into TLRY?
The company will continue to trade on the Nasdaq Global Select Exchange under the symbol "TLRY" and will commence trading on the Toronto Stock Exchange under the symbol "TLRY" on May 5. Under the terms, Aphria shareholders receive 0.8381 of a Tilray share for each common share of Aphria.May 3, 2021
Is Tilray buying Aphria?
In December, Aphria (ticker: APHA) and Tilray (TLRY) announced a plan to merge the two businesses. Aphria would effectively conduct a reverse takeover of Tilray, taking its corporate name and its listing on the Nasdaq, with a 62% interest in the combined company.Apr 16, 2021
Can Tilray recover?
The analysts following Tilray expect it to perhaps double its 2021 revenues in fiscal 2022. That means that it is possible for Tilray to reach $4 billion in 2024 if its trajectory continues as it has. In other words, it doubles in 2022 to reach $1 billion in revenue.Jan 4, 2022
Why is Tilray down?
Shares of Tilray were down after the company reported a wider-than-expected net loss in the fourth quarter despite a beat in revenue.
What is the Aphria Tilray deal?
Under the deal, structured as a reverse acquisition of Tilray, each Aphria shareholder will receive 0.8381 Tilray shares for each Aphria share held. That means Aphria shareholders would own roughly 62% of outstanding Tilray shares.May 3, 2021
Did TLRY and APHA merge?
Tilray Inc. TLRY, -0.47% shareholders voted to approve the Canadian cannabis company's proposed merger with Aphria Inc. apha ca:apha at a special meeting on Friday, according to media reports, paving the way for the creation of the world's biggest cannabis company measured by revenue.May 2, 2021
Is Tilray an American company?
(Tilray) is a global pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City, New York. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.
There appears to be a lack of professional enthusiasm for the stock following the company's big announcement
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
What happened
Marijuana stock Aphria ( NASDAQ:APHA) declined notably on Monday, shedding almost 5.8% of its value. While investors have already digested last week's news of the company's merger with peer Canadian weedie Tilray ( NASDAQ:TLRY), other factors might be affecting sentiment on the stock.
So what
As is usually the case in notable mergers, several prognosticators tracking Aphria (and Tilray, while we're at it) revised their analyses. It seems that the ones getting more bearish on Aphria are catching the ears of investors.
Now what
Since marijuana stocks keep getting blasted with bad news, investors are probably looking for much more enthusiastic recommendations to support their investment. Given that the Aphria bulls are really only adding a dollar or several at best to their price targets after the merger announcement, those recommendations don't seem to be forthcoming.
Why was the merger with Tilray delayed?
The merger had got delayed due to the delay in approval from Tilray shareholders. However, the company lowered the quorum requirement for the shareholder meeting and it was eventually approved overwhelmingly towards the end of April.
What is the ticker symbol for Tilray?
After the merger completion, the new entity trades under Tilray’s ticker symbol, “TLRY” on both the US and Canadian stock exchanges. In a press release, Tilray said that the combined entity had proforma revenue of $685 million in the last year.
Is Aphria a Tilray?
Aphria has stopped trading and all Aphria shares are now converted to Tilray shares. The merger had got delayed due to the delay in approval from Tilray shareholders.
Is Tilray a good buy?
Is Tilray stock a buy? Tilray stock has fallen sharply from the peaks. However, it looks a good buy now given the strong fundamentals of the new entity. Cannabis stocks have been on a fire over the last few trading sessions amid renewed hopes of marijuana legalization. Even Amazon has supported the federal legalization of marijuana.
Will Aphria stock make a comeback in 2020?
As cannabis is a highly regulated industry, investors can expect a delay in the roll-out of retail stores in major Canadian provinces. However, Ontario, Canada’s largest retail market for adult-use cannabis, announced changes in the licensing processes, which will increase the number of new retail locations significantly by the end of 2022.
Stock Advisor Canada Returns
Returns since inception, October 2013. Current as of February 8, 2022.
Why did Aprhia sell off?
Aprhia stock and most marijuana stocks sold off Wednesday after the Canadian cannabis producer reported worse-than-expected fiscal fourth-quarter losses, lower cannabis sales and higher costs largely due to a charge it took related to the coronavirus pandemic.
Is Aurora Cannabis merging with Aphria?
BNN Bloomberg reported this month that Aphria and rival Aurora Cannabis discussed the possibility of merging. But talks fell through, after neither side could agree on the makeup of the board and executive compensation.
How much money did the Tilray merger save?
The merger is critical to the survival of both firms. It will save the firms 100 million CAD ($79 million) in pre-tax annual cost synergies. With competition heating up due to years of excess production, Tilray may have a chance of survival.
How much did Aphria trade in 2021?
Aphria traded as high as almost $27 at its peak on Feb. 10 before slumping. In Q2 2021, the company beat expectations as revenue grew. It lost money again in the period.
How long will CGC stock last in 2023?
Operating cash flow will not be positive for the full year in FY 2023. It will take another three years (FY 2024) when the company achieves positive free cash flow. CGC stock is only for investors with a time frame of at least three years.
Does canopy growth have financials?
The first half of Canopy Growth’s Q3 earnings results presentation did not include financials. Instead, the company touted its product innovations. For example, the National Animal Supplement Council granted Canopy Animal Health its quality seal.
How much medical cannabis is in Germany?
The German medical cannabis market is growing — and growing rapidly. During the first half of 2019, Germany imported an estimated almost 2,500 kilograms of medical cannabis for pharmacy dispensing, which is almost as much as imports in the full year of 2018.
How much cannabis is imported into Germany?
During the first half of 2019, Germany imported an estimated almost 2,500 kilograms of medical cannabis for pharmacy dispensing, which is almost as much as imports in the full year of 2018. Earlier this month, Aphria’s wholly-owned subsidiary entered in a four-year, non-exclusive, distribution agreement to supply monthly shipments ...
